345 related articles for article (PubMed ID: 32335140)
1. A selective Na
Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF
Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140
[TBL] [Abstract][Full Text] [Related]
2. Selective Na
Richards KL; Milligan CJ; Richardson RJ; Jancovski N; Grunnet M; Jacobson LH; Undheim EAB; Mobli M; Chow CY; Herzig V; Csoti A; Panyi G; Reid CA; King GF; Petrou S
Proc Natl Acad Sci U S A; 2018 Aug; 115(34):E8077-E8085. PubMed ID: 30076230
[TBL] [Abstract][Full Text] [Related]
3. Dravet Syndrome: A Developmental and Epileptic Encephalopathy.
Lopez-Santiago L; Isom LL
Epilepsy Curr; 2019 Jan; 19(1):51-53. PubMed ID: 30838929
[TBL] [Abstract][Full Text] [Related]
4. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome.
Goff KM; Goldberg EM
Elife; 2019 Jul; 8():. PubMed ID: 31282864
[TBL] [Abstract][Full Text] [Related]
6. dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.
Colasante G; Lignani G; Brusco S; Di Berardino C; Carpenter J; Giannelli S; Valassina N; Bido S; Ricci R; Castoldi V; Marenna S; Church T; Massimino L; Morabito G; Benfenati F; Schorge S; Leocani L; Kullmann DM; Broccoli V
Mol Ther; 2020 Jan; 28(1):235-253. PubMed ID: 31607539
[TBL] [Abstract][Full Text] [Related]
7. Ndnf Interneuron Excitability Is Spared in a Mouse Model of Dravet Syndrome.
Liebergall SR; Goldberg EM
J Neurosci; 2024 Apr; 44(17):. PubMed ID: 38443186
[TBL] [Abstract][Full Text] [Related]
8. Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome.
Wengert ER; Wagley PK; Strohm SM; Reza N; Wenker IC; Gaykema RP; Christiansen A; Liau G; Patel MK
Brain Res; 2022 Jan; 1775():147743. PubMed ID: 34843701
[TBL] [Abstract][Full Text] [Related]
9. Human Nav1.6 Channels Generate Larger Resurgent Currents than Human Nav1.1 Channels, but the NavĪ²4 Peptide Does Not Protect Either Isoform from Use-Dependent Reduction.
Patel RR; Barbosa C; Xiao Y; Cummins TR
PLoS One; 2015; 10(7):e0133485. PubMed ID: 26182346
[TBL] [Abstract][Full Text] [Related]
10. Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome.
Tai C; Abe Y; Westenbroek RE; Scheuer T; Catterall WA
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3139-48. PubMed ID: 25024183
[TBL] [Abstract][Full Text] [Related]
11. NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome.
Weuring WJ; Singh S; Volkers L; Rook MB; van 't Slot RH; Bosma M; Inserra M; Vetter I; Verhoeven-Duif NM; Braun KPJ; Rivara M; Koeleman BPC
PLoS One; 2020; 15(3):e0219106. PubMed ID: 32134913
[TBL] [Abstract][Full Text] [Related]
12. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.
Schutte RJ; Schutte SS; Algara J; Barragan EV; Gilligan J; Staber C; Savva YA; Smith MA; Reenan R; O'Dowd DK
J Neurophysiol; 2014 Aug; 112(4):903-12. PubMed ID: 24805083
[TBL] [Abstract][Full Text] [Related]
13. Functional Investigation of a Neuronal Microcircuit in the CA1 Area of the Hippocampus Reveals Synaptic Dysfunction in Dravet Syndrome Mice.
Almog Y; Mavashov A; Brusel M; Rubinstein M
Front Mol Neurosci; 2022; 15():823640. PubMed ID: 35370551
[TBL] [Abstract][Full Text] [Related]
14. Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome.
Anderson LL; Hawkins NA; Thompson CH; Kearney JA; George AL
Sci Rep; 2017 May; 7(1):1682. PubMed ID: 28490751
[TBL] [Abstract][Full Text] [Related]
15. Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome.
Kalume F; Oakley JC; Westenbroek RE; Gile J; de la Iglesia HO; Scheuer T; Catterall WA
Neurobiol Dis; 2015 May; 77():141-54. PubMed ID: 25766678
[TBL] [Abstract][Full Text] [Related]
16. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.
Rubinstein M; Westenbroek RE; Yu FH; Jones CJ; Scheuer T; Catterall WA
Neurobiol Dis; 2015 Jan; 73():106-17. PubMed ID: 25281316
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotides restore excitability, GABA signalling and sodium current density in a Dravet syndrome model.
Yuan Y; Lopez-Santiago L; Denomme N; Chen C; O'Malley HA; Hodges SL; Ji S; Han Z; Christiansen A; Isom LL
Brain; 2024 Apr; 147(4):1231-1246. PubMed ID: 37812817
[TBL] [Abstract][Full Text] [Related]
18. Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome.
Cheah CS; Yu FH; Westenbroek RE; Kalume FK; Oakley JC; Potter GB; Rubenstein JL; Catterall WA
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14646-51. PubMed ID: 22908258
[TBL] [Abstract][Full Text] [Related]
19. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.
Cheah CS; Lundstrom BN; Catterall WA; Oakley JC
J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705
[TBL] [Abstract][Full Text] [Related]
20. Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome.
Gu F; Parada I; Yang T; Longo FM; Prince DA
Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35165147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
